nach oben

Erschienen in:

04.07.2019

Impact of comorbidities and functional impairment on 5-year loss of health utility in patients with lower-limb osteoarthritis in the KHOALA cohort

verfasst von: Abdou Y. Omorou, Hamza Achit, Maud Wieczorek, Jacques Pouchot, Bruno Fautrel, Anne-Christine Rat, Francis Guillemin

Erschienen in: Quality of Life Research | Ausgabe 11/2019

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config

KI-gestützte Suche

Aus

Abstract

Purpose

To examine the respective and combined impact of “hypothetical” functional impairment (FI) and burden of comorbidities accrual on a 5-year risk of health utility (HU) loss in osteoarthritis (OA).

Methods

Participants of the Knee and Hip Osteoarthritis Long-term Assessment (KHOALA) study with a 5-year follow-up were included. FI, number of comorbidities and HU were measured annually by the WOMAC, Functional Comorbidity Index and Short-Form 6D, respectively. We estimated the population risk of HU loss (PRD: population risk difference, PRR: population risk ratio) under hypothetical FI and comorbidities using the parametric G-formula. Then, mediation analysis investigated the causal mechanism of comorbidities on HU through FI by estimating total, direct and indirect effects.

Results

We examined data from 767 patients (68.8% women; 61.6 years). The estimated 5-year risk of HU loss was 47.5% [41.9; 52.2] under natural course and 24.9% [15.5; 34.2] when imposing “Patient acceptable function and No comorbidity” corresponding to a PRD = − 22.6 [− 26.5; − 21.2] and a PRR = 0.5 [0.4; 0.6]. The estimated total risk of HU loss comparing “Two comorbidities” versus “No comorbidity” was significant without mediation effect of FI: Total = 10.1% [6.8; 12.9]; direct = 8.0% [2.7; 13.1]; indirect = 2.1% [− 2.0; 5.2].

Conclusions

FI and comorbidities are important and independent determinants of HU loss in patient with OA. Half of cases (50%) of HU loss during 5 years could be avoided by preventing comorbidities (30%) and limiting FI under patient acceptable function (20%). Caregivers should additionally pay close attention to the prevention and the treatment of comorbidities in routine management of OA.

Vorheriger Artikel Emotional problems and health-related quality of life: population-based study

Nächster Artikel Disabled life expectancy with and without stroke: a 10-year Japanese prospective cohort study

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 340 Zeitschriften

aus folgenden Fachgebieten:

Bauwesen + Immobilien
Business IT + Informatik
Finance + Banking
Management + Führung
Marketing + Vertrieb
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Lankhorst, N. E., Damen, J., Oei, E. H., Verhaar, J. A. N., Kloppenburg, M., Bierma-Zeinstra, S. M. A., et al. (2017). Incidence, prevalence, natural course and prognosis of patellofemoral osteoarthritis: The cohort hip and cohort knee study. Osteoarthritis and Cartilage, 25(5), 647–653. https://doi.org/10.1016/j.joca.2016.12.006.CrossRefPubMed

Guillemin, F., Rat, A. C., Mazieres, B., Pouchot, J., Fautrel, B., Euller-Ziegler, L., … 3000 Osteoarthritis group. (2011). Prevalence of symptomatic hip and knee osteoarthritis: A two-phase population-based survey. Osteoarthritis and cartilage/OARS, Osteoarthritis Research Society, 19(11), 1314–1322. https://doi.org/10.1016/j.joca.2011.08.004 CrossRef

Feinstein, A. R. (1970). The pre-therapeutic classification of co-morbidity in chronic disease. Journal of Chronic Diseases, 23(7), 455–468.CrossRef

Sharif, B., Kopec, J., Bansback, N., Rahman, M. M., Flanagan, W. M., Wong, H., … Anis, A. (2015). Projecting the direct cost burden of osteoarthritis in Canada using a microsimulation model. Osteoarthritis and Cartilage, 23(10), 1654–1663. https://doi.org/10.1016/j.joca.2015.05.029 CrossRef

Sharif, B., Garner, R., Hennessy, D., Sanmartin, C., Flanagan, W. M., & Marshall, D. A. (2017). Productivity costs of work loss associated with osteoarthritis in Canada from 2010 to 2031. Osteoarthritis and Cartilage, 25(2), 249–258. https://doi.org/10.1016/j.joca.2016.09.011.CrossRefPubMed

Salmon, J. H., Rat, A. C., Sellam, J., Michel, M., Eschard, J. P., Guillemin, F., … Fautrel, B. (2016). Economic impact of lower-limb osteoarthritis worldwide: A systematic review of cost-of-illness studies. Osteoarthritis and Cartilage, 24(9), 1500–1508. https://doi.org/10.1016/j.joca.2016.03.012 CrossRef

Torrance, G. W. (1987). Utility approach to measuring health-related quality of life. Journal of Chronic Diseases, 40(6), 593–603.CrossRef

Hosseini, K., Gaujoux-Viala, C., Coste, J., Pouchot, J., Fautrel, B., Rat, A.-C., et al. (2012). Impact of co-morbidities on measuring indirect utility by the Medical outcomes study short form 6D in lower-limb osteoarthritis. Best Practice & Research Clinical Rheumatology, 26(5), 627–635. https://doi.org/10.1016/j.berh.2012.08.007.CrossRef

Keil, A. P., Edwards, J. K., Richardson, D. B., Naimi, A. I., & Cole, S. R. (2014). The parametric g-formula for time-to-event data: Intuition and a worked example. Epidemiology (Cambridge, Mass), 25(6), 889–897. https://doi.org/10.1097/ede.0000000000000160.CrossRef

10.

Guillemin, F., Rat, A.-C., Roux, C. H., Fautrel, B., Mazieres, B., Chevalier, X., … KHOALA cohort study. (2012). The KHOALA cohort of knee and hip osteoarthritis in France. Joint, Bone, Spine: Revue Du Rhumatisme, 79(6), 597–603. https://doi.org/10.1016/j.jbspin.2012.03.011 CrossRef

11.

Ware, J. E., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30(6), 473–483.CrossRef

12.

Brazier, J., Usherwood, T., Harper, R., & Thomas, K. (1998). Deriving a preference-based single index from the UK SF-36 health survey. Journal of Clinical Epidemiology, 51(11), 1115–1128.CrossRef

13.

Brazier, J., Roberts, J., & Deverill, M. (2002). The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics, 21(2), 271–292.CrossRef

14.

Bellamy, N., Buchanan, W. W., Goldsmith, C. H., Campbell, J., & Stitt, L. W. (1988). Validation study of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. The Journal of Rheumatology, 15(12), 1833–1840.PubMed

15.

Faucher, M., Poiraudeau, S., Lefevre-Colau, M. M., Rannou, F., Fermanian, J., & Revel, M. (2004). Assessment of the test-retest reliability and construct validity of a modified WOMAC index in knee osteoarthritis. Joint, Bone, Spine: Revue Du Rhumatisme, 71(2), 121–127. https://doi.org/10.1016/S1297-319X(03)00112-X.CrossRef

16.

Groll, D. L., To, T., Bombardier, C., & Wright, J. G. (2005). The development of a comorbidity index with physical function as the outcome. Journal of Clinical Epidemiology, 58(6), 595–602. https://doi.org/10.1016/j.jclinepi.2004.10.018.CrossRefPubMed

17.

Pham, T., & Tubach, F. (2009). Patient acceptable symptomatic state (PASS). Joint, Bone, Spine: Revue Du Rhumatisme, 76(4), 321–323. https://doi.org/10.1016/j.jbspin.2009.03.008.CrossRef

18.

Tubach, F., Ravaud, P., Baron, G., Falissard, B., Logeart, I., Bellamy, N., … Dougados, M. (2005). Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: The patient acceptable symptom state. Annals of the Rheumatic Diseases, 64(1), 34–37. https://doi.org/10.1136/ard.2004.023028 CrossRef

19.

Taubman, S. L., Robins, J. M., Mittleman, M. A., & Hernán, M. A. (2009). Intervening on risk factors for coronary heart disease: An application of the parametric g-formula. International Journal of Epidemiology, 38(6), 1599–1611. https://doi.org/10.1093/ije/dyp192.CrossRefPubMedPubMedCentral

20.

Lin, S.-H., Young, J. G., Logan, R., & VanderWeele, T. J. (2017). Mediation analysis for a survival outcome with time-varying exposures, mediators, and confounders. Statistics in Medicine, 36(26), 4153–4166. https://doi.org/10.1002/sim.7426.CrossRefPubMedPubMedCentral

21.

Kuntz, K. M. (2016). Decision modeling for cost-utility analysis. Value in Health: The Journal of the International Society for Pharmacoeconomics and Outcomes Research, 19(6), 700–701. https://doi.org/10.1016/j.jval.2016.06.003.CrossRef

22.

Mo, F., Choi, B. C. K., Li, F. C. K., & Merrick, J. (2004). Using health utility index (HUI) for measuring the impact on health-related quality of Life (HRQL) among individuals with chronic diseases. TheScientificWorldJournal, 4, 746–757. https://doi.org/10.1100/tsw.2004.128.CrossRefPubMedPubMedCentral

Titel: Impact of comorbidities and functional impairment on 5-year loss of health utility in patients with lower-limb osteoarthritis in the KHOALA cohort
verfasst von: Abdou Y. Omorou
Hamza Achit
Maud Wieczorek
Jacques Pouchot
Bruno Fautrel
Anne-Christine Rat
Francis Guillemin
Publikationsdatum: 04.07.2019
Verlag: Springer International Publishing
Erschienen in: Quality of Life Research / Ausgabe 11/2019
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-019-02243-4

Springer Professional

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu Ihrer Lizenz zu erhalten.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Springer Professional "Wirtschaft"

Weitere Artikel der Ausgabe 11/2019

Emotional problems and health-related quality of life: population-based study

Measuring perinatal and postpartum quality of life of women and associated factors in semi-urban Bangladesh

Disabled life expectancy with and without stroke: a 10-year Japanese prospective cohort study

Preliminary development of proxy-rated quality-of-life scales for children and adults with Niemann-Pick type C

Development and initial validation of the chronic hepatitis B quality of life instrument (CHBQOL) among Chinese patients

Health-related quality of life at hospital discharge as a predictor for 6-month unplanned readmission and all-cause mortality of acutely admitted older medical patients

Premium Partner